Detection of high-grade cervical dysplasia: Impact of age and Bethesda system terminology

Diagnostic Cytopathology

Volumn 17, Issue 5, 1997, Pages 321-325

  Melnikow, Joy ^a   Nuovo, James ^a   Paliescheskey, Mary ^a   Stewart, Gary K ^b,c   Howell, Lydia ^c   Green, William ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California at Davis ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bethesda system; Human papillomavirus; Pap smears; Positive predictive value

Indexed keywords

ADULT; AGE; ARTICLE; BIOPSY; COLPOSCOPY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NOMENCLATURE; PAPANICOLAOU TEST; PREDICTION; PRIORITY JOURNAL; UTERINE CERVIX DYSPLASIA; WART VIRUS;

ADULT; AGE FACTORS; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0030708905     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199711)17:5<321::AID-DC3>3.0.CO;2-D     Document Type: Article

References (29)

1. Koss L. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989;261:737-743.
2. Woolf SH. Screening for cervical cancer. In: Goldbloom RB. Lawrence. RS. eds. Preventing disease: beyond the rhetoric. New York: Springer Verlag. 1990:319-321.
3. Canadian Task Force on Periodic Health Examination. The Canadian guide to clinical preventive health care. Ottawa: Minister of Supply and Services. Canada. 1994:884-889.
4. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnosis. JAMA 1989;262:931-945.
5. Kurmun RJ. Soloman D. The Bethesda system for reporting cervical/ vaginal cytologic diagnosis. New York: Springer Verlag. 1994:30-59.
6. DiSaia PJ. Creasman W. Clinical gynecologic oncology. St. Louis: Mosby-Year Book. 1993:17-24.
7. Melnikow J, Sierk A, Flocke S, Peters C. Does the system of Pap smear nomenclature affect the rate of referral for colposcopy? A survey of family physicians. Arch Fam Med 1993;2:253-258.
8. Miller AB, Anderson J, Brisson J, et al. Report of a national workshop on screening for cancer of the cervix. Can Med Assoc J 1991;145:1301-1325.
9. Kurman RJ, Hensen DE, Herbst AL, Noller KL, Schiffman MH. for the 1992 National Cancer Institute Workshop. Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1866-1869.
10. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long term follow-up. Obstet Gynecol 1986;67:665-669.
11. Miller AB, Knight J, Narod S. The natural history of cancer of the cervix and implications for screening policy. In: Miller AB, Chamberlain J. Day NE. Hakama M. Prorok PC, eds. Cancer screening, New York: Cambridge University Press. 1991;141-152.
12. Melnikow J, Nuovo J, Paliescheskey M. Management of squamous atypia on Papanicolaou smear: A toss up? Med Care 1996;34:336-347.
13. Soutter WP, Wisdom S, Brough AK, Monaghan JM. Should patients with mild atypia in a cervical smear be referred for colposcopy? Br J Obstet Gynuecol 1986;93:70-74.
14. Richart RM, Wright TC, Controversies in the management of lowgrade cervical intraepthelial neoplasia. Cancer 1993;71:1413-1421.
15. Sackett DI., Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology. 2nd ed. Boston. Toronto, and London: Little. Brown and Company. 1991:69-152.
16. Sadeghi SB, Sadeghi A, Robboy SJ. Prevalence of dysplasia and cancer of the cervix in a nationwide Planned Parenthood population. Cancer 1988;61:2359-2361.
17. Benedet JL, Anderson OH, Matisic JP. A comprehensive program for cervical cancer detection and management. Am J Obstet Gynecol 1992;166:1254-1259.
18. Van Oortmarssen GJ, Habbema JDF, Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer 1992;64:559-565.
19. Herbst AL. The Bethesda system for cervical/vaginal cytologic diagnoses: a note of caution. Obstel Gynecol 1990;76:449-450.
20. Nuovo GJ. Cytopathology of the lower female genital tract. Baltimore: Williams and Wilkins. 1994:156.
21. Sidawy MK, Siriaunkgul S, Frost AR. Retrospective analysis of non-correlating cervical smears and colposcopically directed biopsies. Diagn Cytopathol 1994;11:343-347.
22. Kainz C, Templer C, Gitsch G, Heinzl H, Reinthaller A, Breitenecker G. Influence of age and human papillomavirus-infection on reliability of cervical cytopathology. Arch Gynecol Obster 1995;256:23-28.
23. Lonky NM, Navarre GL, Saunders S, Sadeghi M, Wolde-Tsadik G. Low-grade Papanicolaou smeurs and the Bethesda system: a prospective cytohistopathologic analysis. Obstet Gynecol 1995;85:716-720.
24. Russell L. Educated guesses: making policy about medical screening tests. Berkeley: University of California Press, 1994:6-25.
25. Nasiell K, Nasiell M, Vaclavinkova V. Behavior of moderate cervical dysplasia during long term follow-up. Obslet Gynecol 1983;61: 609-614.
26. Richart RM, Burron BA, Screening strategies for cervical cancer and cervical intraepithelial neoplasia. Cancer 1981;47:1176-1181.
27. Hatch KD, Schneider A, Ahdel-Nour MW, An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy, Am J Obstet Gynecol 1995;172:1150-1157.
28. Staft A. Cervicography: a new method for cervical cancer detection. Am J Obstet Gynecol 1981;139:815-825.
29. Johnson K. with the Canadian Task Force on Periodic Health Examination. Periodic health examination. 1995 update: J. Screening for human papillomavirus infection in asymptomatic women. Can Med Assoc J 1995;152:483-493.